Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review
Field | Value | Language |
dc.contributor.author | Watts, CG | |
dc.contributor.author | Dieng, M | |
dc.contributor.author | Morton, RL | |
dc.contributor.author | Mann, G | |
dc.contributor.author | Menzies, S | |
dc.contributor.author | Cust, AE | |
dc.date.accessioned | 2022-08-23T02:57:44Z | |
dc.date.available | 2022-08-23T02:57:44Z | |
dc.date.issued | 2014 | en_AU |
dc.identifier.uri | https://hdl.handle.net/2123/29442 | |
dc.description.abstract | Understanding how individuals at high-risk of primary cutaneous melanoma are best identified, screened and followed up will help optimize melanoma prevention strategies and clinical management. We conducted a systematic review of international clinical practice guidelines and documented the quality of supporting evidence for recommendations for clinical management of individuals at high risk of melanoma. | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | British Journal of Dermatology | en_AU |
dc.rights | Creative Commons Attribution 4.0 | en_AU |
dc.subject | melanoma | en_AU |
dc.subject | high-risk | en_AU |
dc.subject | screening | en_AU |
dc.subject | identification | en_AU |
dc.subject | clinical practice guidelines | en_AU |
dc.title | Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review | en_AU |
dc.type | Article | en_AU |
dc.subject.asrc | 1117 Public Health and Health Services | en_AU |
dc.identifier.doi | 10.1111/bjd.13403 | |
dc.type.pubtype | Publisher's version | en_AU |
usyd.faculty | SeS faculties schools::Faculty of Medicine and Health::NHMRC Clinical Trials Centre | en_AU |
workflow.metadata.only | No | en_AU |
Associated file/s
Associated collections